Steven Hu, Ph.D., and Peng Dai, Ph.D., of Asymchem discuss the CDMO's technology-driven global expansion, its new R&D center just outside of Boston, Massachusetts, that has been supporting drug developers since the beginning of 2023, and the next steps in its ongoing globalization strategy to serve emerging biotech and biopharma companies in the West.
.svg)
